Nephrology & Urology Clinical Trials

Statistical methods in nephrology & urology trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All nephrology & urology trials

405 results

• Functional MRI Use in Prostate Radiation Treatment Planning: Complete Statistical AnalysisIndependent statistical analysis of Functional MRI Use in Prostate Radiation Treatment Planning: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01985932).Phase NAResults postedn = 15NCT01985932
• G-MINORIndependent statistical analysis of Genomics in Michigan Impacting Observation or Radiation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02783950).Phase NAResults postedn = 356NCT02783950
• Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD): Complete Statistical AnalysisIndependent statistical analysis of Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01138124).Phase NAResults postedn = 54,202NCT01138124
• Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03803475).Phase 3Results postedn = 485NCT03803475
• Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer: Complete Statistical AnalysisIndependent statistical analysis of Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 3Results postedn = 506NCT00942331
• Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery: primary endpoint results, effect estimate with confidence interval,…Phase 2Results postedn = 26NCT02178241
• Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 3: Complete Statistical AnalysisIndependent statistical analysis of Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 3: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00878969).Phase 3Results postedn = 78NCT00878969
• Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy: Complete Statistical AnalysisIndependent statistical analysis of Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 36NCT02099864
• GeniProIndependent statistical analysis of Genistein Supplementation to Mitigate Cardiometabolic Dysfunction in Patients Undergoing Androgen Deprivation Therapy for Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 10NCT02766478
• Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury: Complete Statistical AnalysisIndependent statistical analysis of Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 2/3Results postedn = 23NCT03503513
• GETUGV04Independent statistical analysis of A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 69NCT01495676
• Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency: Complete Statistical AnalysisIndependent statistical analysis of Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 4Results postedn = 114NCT00911625
• GLIMPIndependent statistical analysis of Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2Results postedn = 7NCT05254418
• Global Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Women With Moderate to Severe Endometriosis-associated Pain: Complete Statistical AnalysisIndependent statistical analysis of Global Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Women With Moderate to Severe Endometriosis-associated Pain: primary endpoint results, effect estimate with confidence interval, sample-size…Phase 3Results postedn = 496NCT02143713
• GRAMSIndependent statistical analysis of Gadobutrol Enhanced MRA of the Renal Arteries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01344460).Phase 3Results postedn = 317NCT01344460
• Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing Surgery: Complete Statistical AnalysisIndependent statistical analysis of Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 113NCT00685516
• GreenLight XPS Laser System Retrospective Chart Review: Complete Statistical AnalysisIndependent statistical analysis of GreenLight XPS Laser System Retrospective Chart Review: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02139969).Phase NAResults postedn = 956NCT02139969
• HALT PKD AIndependent statistical analysis of HALT Progression of Polycystic Kidney Disease Study A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00283686).Phase 3Results postedn = 558NCT00283686
• Hand-carried Ultrasound to Assess Hydronephrosis: Complete Statistical AnalysisIndependent statistical analysis of Hand-carried Ultrasound to Assess Hydronephrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03774719).Phase NAResults postedn = 6NCT03774719
• Handgrip Exercise for Arteriovenous Fistula Maturation: Complete Statistical AnalysisIndependent statistical analysis of Handgrip Exercise for Arteriovenous Fistula Maturation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01061008).Phase NAResults postedn = 31NCT01061008
• HDIL2/EmendIndependent statistical analysis of Fosaprepitant for N/V With High-dose Interleukin-2 for Metastatic Melanoma and Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 2Results postedn = 13NCT01874119
• Health Care Personnel Time for Anemia Management With Erythropoiesis Stimulating Agents in Hemodialysis Centers in Croatia: Complete Statistical AnalysisIndependent statistical analysis of Health Care Personnel Time for Anemia Management With Erythropoiesis Stimulating Agents in Hemodialysis Centers in Croatia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase NAResults postedn = 110NCT02625844
• Health Gatherings – For Your Health After Cancer: Complete Statistical AnalysisIndependent statistical analysis of Health Gatherings - For Your Health After Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03344757).Phase NAResults postedn = 188NCT03344757
• HELPS-HDIndependent statistical analysis of Health Effects of oraL Protein Supplements in HD (The HELPS-HD Trial): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 10,457NCT02933151
• Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure: Complete Statistical AnalysisIndependent statistical analysis of Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2/3Results postedn = 55NCT00318812
• HEROIndependent statistical analysis of A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 3Results postedn = 1,134NCT03085095
• High-dose Bevacizumab in Advanced Renal Carcinoma Patients: Complete Statistical AnalysisIndependent statistical analysis of High-dose Bevacizumab in Advanced Renal Carcinoma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00455975).Phase 2Results postedn = 119NCT00455975
• Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy: Complete Statistical AnalysisIndependent statistical analysis of Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03388619).Phase 1Results postedn = 30NCT03388619
• HiLo: Pragmatic Trial of Higher vs Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis: Complete Statistical AnalysisIndependent statistical analysis of HiLo: Pragmatic Trial of Higher vs Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 793NCT04095039
• HiRTIndependent statistical analysis of Hyperglycemia in Renal Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01643382).Phase NAResults postedn = 60NCT01643382
• HIV and Kidney Function Study: Complete Statistical AnalysisIndependent statistical analysis of HIV and Kidney Function Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00905151).Phase NAResults postedn = 206NCT00905151
• HOP-2AIndependent statistical analysis of HOP-2A - Intratesticular Hormone Levels: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00756561).Phase NAResults postedn = 10NCT00756561
• Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 3Results postedn = 350NCT00116142
• Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 2Results postedn = 19NCT02560051
• Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2Results postedn = 20NCT04011410
• Hyp-hOPIndependent statistical analysis of Brain-Centered Therapy Versus Medication for Urgency Urinary Incontinence : Hypnotherapy Or Pharmacotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 165NCT01829425
• IDEAL-ICUIndependent statistical analysis of IDEAL-ICU, a randomized phase 3 trial evaluating early versus delayed initiation of renal replacement therapy in ICU patients with septic shock and acute renal failure.Phase 3n = 500NCT01682590
• IGNAZIndependent statistical analysis of Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 2Results postedn = 54NCT05065970
• IMmotion151Independent statistical analysis of A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC): primary endpoint results, effect estimate with confidence interval, sample-size…Phase 3Results postedn = 915NCT02420821
• Immuno-nutrition Supplementation in Haemodialysis: Complete Statistical AnalysisIndependent statistical analysis of Immuno-nutrition Supplementation in Haemodialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05700851).Phase NAResults postedn = 17NCT05700851
• Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04936230).Phase 2Results postedn = 1NCT04936230
• Impact of Behavioral Treatment of Insomnia on Nighttime Urine Production: Complete Statistical AnalysisIndependent statistical analysis of Impact of Behavioral Treatment of Insomnia on Nighttime Urine Production: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03883724).Phase NAResults postedn = 56NCT03883724
• Impact of DNA Fragmentation in Sperm on Pregnancy Outcome After Intra-uterine Insemination in a Spontaneous Cycle: Complete Statistical AnalysisIndependent statistical analysis of Impact of DNA Fragmentation in Sperm on Pregnancy Outcome After Intra-uterine Insemination in a Spontaneous Cycle: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase NAResults postedn = 120NCT03319654
• Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery: Complete Statistical AnalysisIndependent statistical analysis of Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02352103).Phase 3Results postedn = 120NCT02352103
• Improving Care for Women With Urinary Incontinence (EMPOWER): Complete Statistical AnalysisIndependent statistical analysis of Improving Care for Women With Urinary Incontinence (EMPOWER): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05515198).Phase NAResults postedn = 400NCT05515198
• Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD: Complete Statistical AnalysisIndependent statistical analysis of Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05734989).Phase NAResults postedn = 248NCT05734989
• Improving Urinary Continence and Quality of Life in Prostate Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Improving Urinary Continence and Quality of Life in Prostate Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 279NCT01365182
• Incisional Negative Pressure Wound Therapy in High Risk Patients Undergoing Panniculectomy: A Prospective Randomized Controlled Trial: Complete Statistical AnalysisIndependent statistical analysis of Incisional Negative Pressure Wound Therapy in High Risk Patients Undergoing Panniculectomy: A Prospective Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase NAResults postedn = 30NCT03010137
• Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning: Complete Statistical AnalysisIndependent statistical analysis of Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02470910).Phase NAResults postedn = 15NCT02470910
• Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy: primary endpoint results, effect estimate with confidence interval,…Phase NAResults postedn = 550NCT03860961

← All therapeutic areas